Open Access

Alcohol consumption and risk of subarachnoid hemorrhage: A meta-analysis of 14 observational studies

  • Authors:
    • Xiyang Yao
    • Kai Zhang
    • Jieyong Bian
    • Gang Chen
  • View Affiliations

  • Published online on: August 23, 2016     https://doi.org/10.3892/br.2016.743
  • Pages: 428-436
  • Copyright: © Yao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The association between alcohol consumption and the risk of subarachnoid hemorrhage (SAH) is inconsistent. Thus, meta‑ and a dose-response analyses are presented with the purpose of assessing their associations. A systematic literature search was performed using Pubmed and Embase electronic databases for pertinent observational studies. Random‑effects or fixed‑effect models were employed to combine the estimates of the relative risks (RRs) with corresponding 95% confidence intervals (CIs). A dose‑response pattern was conducted for further analysis. The current meta‑analysis includes 14 observational studies reporting data on 483,553 individuals and 2,556 patients. The combined RRs of light alcohol consumption (<15 g/day) and moderate alcohol consumption (15‑30 g/day) compared with teetotal individuals were 1.27 (95% CI: 0.95, 1.68) and 1.33 (95% CI: 0.84, 2.09), respectively, which indicated no significant association between light‑to‑moderate alcohol consumption and SAH. An increased risk of SAH was noted in heavy alcohol consumption (>30 g/day) when compared with no alcohol consumption, as demonstrated by a result of 1.78 (95% CI: 1.46, 2.17). Dose‑response analysis showed evidence of a linear association (P=0.0125) between alcohol consumption and SAH. The risk of SAH increased by 12.1% when alcohol consumption was increased by 10 g/day. Therefore, heavy alcohol consumption was found to be associated with an increased risk of SAH. Furthermore, the association between SAH and alcohol consumption has clinical relevance with regard to risk factor modification and the primary and secondary prevention of SAH.

Introduction

Subarachnoid hemorrhage (SAH) is a destructive type of stroke, which contributes to ≥30% patients succumbing due to the original hemorrhage and rehemorrhage despite the development of novel treatment strategies (17). Although SAH is rare, it has a marked impact, particularly on young individuals, and poor outcomes (2,8,9). Therefore, it is vital to investigate the risk factors of SAH and attempt to prevent these with the aim of reducing the incidence of SAH. Alcohol consumption is common throughout the world and numerous observational studies have analyzed the role of alcoholic beverage intake and SAH, with some demonstrating alcohol as a risk factor or some presenting an unclear association (1023).

In previous studies, alcohol intake and the risk of hemorrhagic stroke were investigated in the two meta-analyses, whereas intracerebral hemorrhage (ICH) and SAH were not classified in either of the studies (24,25). Furthermore, their investigative consequences primarily represented ICH, as the incidence of ICH was double that of SAH (26). The impacts of alcohol consumption on the incidence of SAH are inconclusive and limited. Another two systematic reviews presented the association between alcohol intake and the risk of SAH; however, the alcohol consumption level was inexact and a further association was not identified through dose-response analysis (27,28). Thus, the current meta-analysis, which included a dose-response analysis, was performed based on previous observational studies with the aim of identifying the specific association between various levels of alcohol consumption and the risk of SAH.

Materials and methods

Study selection

This meta-analysis was conducted on the basis of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement issued in 2009 (29). A systematic literature search of the Pubmed (http://www.ncbi.nlm.nih.gov/pubmed) and Embase (http://www.embase.com) electronic databases for pertinent studies published from their inception to 20 January 2016 was performed by two authors (Mr. Xiyang Yao and Dr Gang Chen) independently. The search strategy used terms as follows: ‘Subarachnoid hemorrhage’ AND (‘alcohol’ OR ‘alcoholic beverages’ OR ‘ethanol’ OR ‘wine’ OR ‘liquor’ OR ‘spirits’ OR ‘beer’). No language restriction was set. In addition, a manual search of the probable missing publications of interest in our previous literature search was based on the reference lists of relevant studies.

Publications included in our meta-analysis complied with the following criteria: i) A study of the association between alcohol consumption and SAH; ii) case-control or cohort studies; iii) the effect estimate [relative risk (RR), hazard ratio (HR), odd ratio (OR)] and its corresponding 95% confidence intervals (CIs) were supplied (or enough data to calclulate them); iv) alcohol consumption was classified by quantity; v) the most informative study remained in the current meta-analysis if two or more published reports were based on the same research population.

Data abstraction and quality assessment

The following data were collected: First author's last name, published year, country, study design, assessment of alcohol consumption, sample size, female proportion, age at baseline, follow up duration (years), effect estimate and its 95% CI, and matched or adjusted factors. The Newcastle-Ottawa Scale (NOS) (30) was selected to assess the quality of the included studies. The NOS is composed of three subscales as follows: Selection, comparability and outcome. Furthermore, it includes a range from 0 to 9 stars, and a study was considered to be of high quality when it obtained ≥7 stars. Two authors (Mr. Xiyang Yao and Dr Gang Chen) gathered the data and evaluated the study quality separately. An additional author inspected and adjudicated the information according to the original studies.

Statistical analysis

RR with 95% CI measured the association between alcohol consumption and SAH. As the prevalence of SAH was relatively low, ORs and HRs were directly considered to be RRs (31). Adjusted RRs were employed in the meta-analysis and the crude data was used when the study didn't provide the adjusted data. The Q-statistic (P<0.1 was identified as statistically significant) and I2 percentage (I2: <50%, low heterogeneity; 50–75%, moderate heterogeneity; >75%, high heterogeneity) were used to evaluate the statistical heterogeneity between studies (32,33). The random-effects model was used when heterogeneity existed between studies and a fixed model was adopted otherwise (34). Subgroup analyses were performed according to gender, study design, geographic area, matched or adjusted status and study quality. Sensitivity analyses were conducted by omitting one study each time to evaluate the influence of the single study on the remaining studies. In addition, publication bias for the association between alcohol consumption and the risk of SAH was statistically assessed by Egger test (35) and Begg's test (36). P<0.05 was considered to indicate a statistically significant difference. When publication bias was apparent the ‘trim and fill’ method was used to modify it (37).

One drink was defined as 12.5 g, with 1 ml as 0.8 g and 1 oz as 28.35 g ethanol, and used grams of ethanol per day (g/day) as a standard measurement of alcohol consumption (38). The midpoint of each classification was taken as the quantity of alcohol consumption per day. When referring to the open-ended upper dose classification, it was counted as 1.2 times that of the lower bound for analyses (39). Non-drinkers were regarded as the reference category. Alcohol consumption was placed in three categories as follows: Light, <15 g/day; moderate, 15–30 g/day; and heavy, >30 g/day (25). When more than one category fell into one alcohol consumption level in certain studies, the RRs within a single category were combined for each study after which all studies were pooled (24). A dose-response analysis by generalized least squares regression models (40) was performed for further analysis and alcohol consumption (g/day) was considered as the explanatory variable. The potential curve linear correlation with alcohol consumption and SAH was evaluated using restricted cubic splines with three knots at percentiles 25, 50 and 75% of the distribution (41). The null hypothesis, where the coefficient of the second spline was equal to 0, was used to assess linearity or non-linearity according to a P-value (42). RRs with 95% CIs, distribution of cases and controls or person-years for at least three quantitative types of classifications have to be provided in initial studies. STATA 12.0 (StataCorp LP, College Station, TX, USA) was used to perform all statistical analyses.

Results

Literature search

Fig. 1 demonstrates the search flow. In total, 1,536 search records were yielded from the PubMed and Embase databases. There were 246 duplicates that were omitted, and 1,251 records were further removed after scanning the titles and abstracts, as these did not meet the inclusion criteria. The remaining 39 records were selected for full-text evaluation and 26 studies were excluded due to the following: Three studies were excluded because they were reviews (4345). Two studies were excluded as they only investigated alcohol consumption within 24 h and one week before SAH, which was not representative of habitual alcohol consumption (46,47). Ten studies (4857) that lacked sufficient data calculating RR estimates, and eight studies (5865) where alcohol consumption had not been quantified were excluded. The remaining three studies reported on the same population (6668). Furthermore, only one additional study of interest was identified during the manual search, which was then included (12). In total, 14 studies (1023) were included in the current meta-analysis of which nine were cohort studies and five were case-control studies.

Study characteristics

The published period of the studies was from 1986 to 2013. Among the 14 studies, five were from the USA (10,11,14,20,22), one was from Britain (19), one was from Finland (18) and seven were from Japan (12,13,1517,21,23). A total of 480,014 individuals were reported in the cohort studies and 35.2% were male. The follow-up period of the cohorts ranged from 3.8 to 17.9 years and the number of participants ranged from 2,890 to 128,934 in every cohort study. In addition, there were 1,182 cases and 2,357 controls from the five case-control studies. Seven of the studies achieved a rating of >6 stars and were, therefore, considered to be high quality. Whereas, the remaining seven studies were considered to be low quality as a result of the star rating. Detailed characteristics are presented in Table I.

Table I.

Key characteristics of the included studies.

Table I.

Key characteristics of the included studies.

Author, year (Refs.)CountrySubjects, nGenderCases, nYears of duration or study periodExposure assessmentAdjusted or matched variablesNOS score
Cohort studies
  Donahue, 1986 (10)USA8006M3212IPIa,b,f,g,i,j,k6
  Stampfer, 1988 (11)USA87526F283.8SAQa5
  Iso, 1995 (12)Japan2890M1810.5IPIa6
  Sankai, 2000 (13)Japan12372M+F719.4IPIa,b,d,f-i8
  Klatsky, 2002 (14)USA128934M+F1337SAQa-d,g,s7
  Yamada, 2003 (15)Japan109293M+F2449.9SAQa7
  Iso, 2004 (16)Japan19544M7311SAQNone7
  Ikehara, 2013 (17)Japan47100F33816.7SAQa,d-f-i,m-o7
  Korja, 2013 (18)Finland64349M+F437Median 17.9SAQa,b6
Case-control studies
  Gill, 1991 (19)Britain766M+F193NRSAQa-d,f,p-q,r6
  Longstreth, 1992 (20)USA447M+F1491987–1989IPIa,b7
  Kubota, 2001 (21)Japan254M+F127NRSAQa,b7
  Qureshi, 2001 (22)USA1292M+F3231990–1997MRa-c4
  Ohkuma, 2003 (23)Japan780M+F3902000–2001SAQNone5

[i] Adjusted or matched variables were: (a) Age, (b) gender, (c) race, (d) cigarette smoking, (e) area, (f) hypertension, (g) BMI, (h) DM, (i) cholesterol, (j) uric acid and glucose concentrations, (k) hematocrit, (l) menopausal status, (m) mental stress, (n) facial redness after alcohol consumption, (o) sports at leisure time, (p) socioeconomic class, (q) treatment of hypertension, (r) medication, (s) education. M, male; F, female; NR, not reported; IPI, in-person interview; SAQ, self-administered questionnaire; MR, medical records; BMI, body mass index; DM, diabetes mellitus.

Alcohol consumption and risk of SAH

Figs. 24 demonstrate the outcomes from the random-effects model (light and moderate alcohol consumption) or fixed-effect model (heavy alcohol consumption) of pooled RRs for SAH. The combined RR of light alcohol consumption (<15 g/day) and moderate alcohol consumption (15–30 g/day) compared with no alcohol consumption were 1.27 (95% CI: 0.95, 1.68; I2=61.9%; P=0.005 for heterogeneity) and 1.33 (95% CI: 0.84, 2.09; I2=59.6%; P=0.022 for heterogeneity), respectively, which indicated no significant association between light or moderate alcohol consumption and SAH. Furthermore, the summary RR showed an increased risk of SAH when heavy alcohol consumption (>30 g/day) was compared with no alcohol consumption, with a pooled result of 1.78 (95% CI: 1.46, 2.17; I2=23.0%; P=0.218 for heterogeneity).

Stratified analyses

To minimize heterogeneity, stratified analyses were conducted between the included studies. The subgroups were generated in terms of pivotal study characteristics: Study design, gender, geographic area, type of SAH, study quality and adjustment status (smoking and blood pressure). The intact stratified results are presented in Table II.

Table II.

Summary RRs for alcohol consumption and SAH.

Table II.

Summary RRs for alcohol consumption and SAH.

Low alcohol consumptionModerate alcohol consumptionHeavy low alcohol consumption



RR (95% CI) P-valueaRR (95% CI) P-valueaRR (95% CI) P-valuea
Total outcomes1.27 (0.95,1.68)   0.101.33 (0.84,2.09)   0.231.78 (1.46,2.17)<0.01
Study design
  Cohort1.53 (1.16,2.02)<0.012.08 (0.90,4.81)   0.091.88 (1.46,2.43)<0.01
  Case-control  0.88 (0.54,1.68)   0.631.33 (0.84,2.09)   0.681.64 (1.20,2.24)<0.01
Gender
  Men1.46 (1.11,1.93)<0.013.5 (1.5,20.7)   0.041.77 (1.36,2.30)<0.01
  Women1.33 (0.82,2.18)   0.252.41 (0.66,8.78)   0.181.27 (0.90,1.79)   0.18
Geographic area
  North America1.63 (0.81,3.27)   0.172.16 (1.29,3.59)<0.012.64 (1.63,4.28)<0.01
  Asia1.26 (0.94,1.70)   0.130.82 (0.62,1.09)   0.171.71 (1.37,2.14)<0.01
  Europe1.02 (0.48,2.16)   0.96//  0.75 (0.28,2.02)   0.57
Type of SAH
  Total SAH1.27 (0.95,1.68)   0.101.61 (1.07,2.44)   0.021.90 (1.50,2.41)<0.01
  aSAH0.80 (0.58,1.09)   0.161.53 (1.06,2.20)   0.02
Study quality
  Low1.49 (0.75,2.98)   0.262.19 (0.54,8.85)   0.271.41 (1.01,1.97)   0.04
  High1.20 (0.91,1.57)   0.201.12 (0.77,1.63)   0.552.02 (1.58,2.59)   0.02
Adjusted smoking
  Yes1.23 (0.62,2.45)   0.561.54 (0.71,3.36)   0.271.62 (1.09,2.39)   0.04
  No1.31 (0.94,1.83)   0.121.25 (0.68,2.30)   0.472.02 (1.45,2.81)<0.01
Adjusted blood pressure
  Yes1.23 (0.62,2.45)   0.571.65 (0.46,5.92)   0.441.64 (0.94,2.87)   0.01
  No1.31 (0.94,1.83)   0.121.27 (0.74,2.18)   0.381.93 (1.44,2.58)<0.01

a P<0.05 was considered to indicate a statistically significant difference. RR, relative risk; CI, confidence interval; SAH, subarachnoid hemorrhage; aSAH, aneurysmal subarachnoid hemorrhage.

For light alcohol consumption, total RRs of light alcohol consumption were not identified to be associated with the risk of SAH and had a moderate heterogeneity. However, if the study design was cohort, light alcohol consumption was observed to have an increased association with the risk of SAH and low heterogeneity, with RR of 1.53 (95% CI: 1.16, 2.02; I2=35.7%; P=0.156 for heterogeneity). Furthermore, the pooled RR of 1.46 (95% CI: 1.11, 1.93; I2=0%; P=0.468 for heterogeneity) was statistically significant and there was no evidence of heterogeneity with regard to men and light alcohol consumption. No further statistically significant data was found in the geographic area, types of SAH, adjustment for smoking, adjustment for blood pressure and study quality.

For moderate alcohol consumption, no statistical significance was identified with the overall RRs of moderate alcohol consumption compared with the risk of SAH, and moderate heterogeneity was indicated. Notably, low heterogeneity was observed and an increased risk between moderate alcohol consumption and SAH was identified when the geographic area was North America and the type of SAH was total SAH. Furthermore, only one study mentioned the data regarding association with moderate alcohol consumption and the risk of SAH in a male population. No statistically significant information was found according to the results of the groups, such as study design, study quality and adjustments.

For heavy alcohol consumption, the RRs of women and adjustment for blood pressure along with heavy alcohol consumption did not show statistical significance with the risk of SAH, while other items indicated a statistically significant increased risk (Table II).

Sensitivity analyses and publication bias

The outcomes of sensitivity analyses were not identified to be significantly varied (data not shown). The Egger test (P=0.906) and Begg's test (P=0.719) indicated no evidence of publication bias for the association with light alcohol consumption and the risk of SAH. For heavy alcohol consumption, similar results were observed with the Egger test (P=0.235) and Begg's test (P=0.493). However, potential evidence of publication bias was found for SAH risk with moderate alcohol consumption according to the Egger test (P=0.004) and Begg's test (P=0.011). The adjusted result from the ‘trim and fill’ method for publication bias was 0.94 (95% CI: 0.57, 1.53), which did not change the former conclusions for SAH risk and moderate alcohol consumption. Fig. 5 demonstrates the funnel plot after applying the ‘trim and fill’ method.

Dose-response association

Seven studies were included in the dose-response analysis of alcohol consumption with SAH risk (10,11,14,16,17,19,20). A linear increase in SAH with increasing alcohol consumption (P=0.013) was observed after accessing dose-response patterns for alcohol consumption (g/day) for alcohol consumers vs. teetotal individuals (Fig. 6). Furthermore, the risk increased by 12.1% for each additional 10 g/day of alcohol consumption.

Discussion

In the past several decades, the role of alcohol intake in the development of SAH has been increasingly recognized. Teunissen et al (27) conducted a systematic review about the risk factors for SAH, which five studies referring to alcohol intake and the risk of SAH. Alcohol abuse was identified to be a significant risk factor for SAH, with the results of drinking ≥21.4 g/day alcohol being RR=4.7 (95% CI: 2.1, 10.5) according to two longitudinal studies, and odds ratio (OR)=1.5 (95% CI: 1.1, 1.9) according to three case control studies. Subsequently, an updated systematic review of epidemiological studies was conducted by the same group, which demonstrated no different conclusions with the inclusion of extra studies (28). The current meta-analysis was based on observational studies that had quantified alcohol consumption with the aim of identifying probable correlations between alcohol consumption and the risks of SAH. The analysis included 483,553 individuals and 2,556 patients from nine cohort and five case-control studies. The results indicated that there was no correlation between light or moderate alcohol consumption and the risk of SAH, while an increased risk of SAH was found to be associated with heavy alcohol consumption. The dose-response analysis evidenced a distinct linear association between alcohol consumption and SAH, which was consistent with the findings of Leppala et al (69). In addition, the dose-response analysis indicated an increased risk of 12.1% for every increase of 10 g/day alcohol when comparing drinkers to teetotal individuals.

The current findings confirmed the results from previous systematic reviews (27,28). Furthermore, the accuracy of the risk estimates was augmented with the accumulative data and stratified analyses were executed to evaluate the origin of heterogeneity (70), thereby advancing the clinical association of the present findings. Subgroup analysis indicated that light alcohol consumption was associated with an increase in SAH risk in cohort studies and men. Smoking was confirmed to be an independent risk factor for SAH (20,21,52,71,72) and men smoked more than women, which may be the explanation for the association between light alcohol consumption and the increased risk of SAH in men. Moderate alcohol consumption was associated with an increased risk of SAH in North American individuals; however, the explanation of this finding was unclear and requires additional investigation to be confirmed. Hypertension (73), reducing platelet aggregation (74) and enhancing fibrinolysis from endothelial cells (75) may be the reasons for the association between an increased risk of SAH and heavy alcohol consumption; although heavy alcohol consumption was not significantly associated with SAH in women. The potential reasons are as follows: i) Heavy drinkers were likely to be inclined to take part in the surveys as participants and less willing to complete repeat questionnaires in detail (11); ii) all volunteers in the study by Stampfer et al (11) were female nurses who may have had knowledge of the negative outcomes of drinking excessively, and therefore avoided heavy drinking (11); and iii) small population number (13,19). Notably, although hypertension has been consistently considered as the strongest predictor of SAH in previous studies (7680), no correlation was found between heavy alcohol consumption and SAH risk in individuals from the included studies, which adjusted for blood pressure (10,13,17,19). However, the association between alcohol and stroke diminished markedly when adjusting for varying hypertension (3).

A notable strength of the present study is that it contains a broader individual population and has a longer follow-up when compared with previous studies. However, when interpreting the outcomes of the current meta-analysis, certain limitations should also be considered. First, the impact of potential confounding factors is a well-known issue resulting from the observational design of all of the included studies. In consideration of an osculating association between alcohol consumption and demographic, family history and lifestyle factors, the residual confounding factor should be categorized distinctly between these variables in future research. Second, information, select and recall bias usually lead to overestimating and underestimating the real associations in the observational studies. Furthermore, evidence of publication bias existed when pooling the results of correlation with moderate alcohol consumption and the risk of SAH, although the conclusion remained unchanged following the ‘trim and fill’ method. Third, the strength of the correlation may have been weakened by misclassification bias. As the alcohol consumption assessment was based on self-reports and self-administered questionnaires, misclassification bias was inevitable. Finally, stratified analyses to examine the influence of different types of alcohol consumption on these correlations were conducted on account of the limited number of studies.

The present findings reveal various implications that are significant to public health. Individuals who reduce their alcohol consumption may also reduce their risk of SAH. Therefore, subjects who are alcohol drinkers should be encouraged to modify their habits to diminish the possibility of heavy alcohol consumption. Although small quantities of alcohol consumption are thought to reduce the risk of ischemic stroke (24,25), alcohol indeed promotes certain types of cancer, such as colorectal and gastric cancer (81,82) and, according to the present meta-analysis, increases the risk of SAH.

In conclusion, heavy alcohol consumption (>30 g/day) is associated with increased risk of SAH. The association between alcohol consumption and SAH has clinical implications for primary and secondary prevention of SAH. The implications of the findings require careful evaluation, as any suggestion regarding alcohol consumption must be tailored to the risks of each individual patient.

Acknowledgements

The present study was supported by Suzhou Key Medical Center (grant no. Szzx201501), grants from the National Natural Science Foundation of China (grant nos. 81571115, 81422013 and 81471196), the Scientific Department of Jiangsu Province (grant no. BL2014045), Suzhou Government (grant nos. LCZX201301, SZS201413 and SYS201332) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.

References

1 

Hanel RA, Xavier AR, Mohammad Y, Kirmani JF, Yahia AM and Qureshi AI: Outcome following intracerebral hemorrhage and subarachnoid hemorrhage. Neurol Res. 24:(Suppl 1). S58–S62. 2002. View Article : Google Scholar : PubMed/NCBI

2 

Johnston SC, Selvin S and Gress DR: The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology. 50:1413–1418. 1998. View Article : Google Scholar : PubMed/NCBI

3 

Hasegawa Y, Suzuki H, Uekawa K, Kawano T and Kim-Mitsuyama S: Characteristics of cerebrovascular injury in the hyperacute phase after induced severe subarachnoid hemorrhage. Transl Stroke Res. 6:458–466. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Marbacher S, Nevzati E, Croci D, Erhardt S, Muroi C, Jakob SM and Fandino J: The rabbit shunt model of subarachnoid haemorrhage. Transl Stroke Res. 5:669–680. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Pluta RM, Bacher J, Skopets B and Hoffmann V: A non-human primate model of aneurismal subarachnoid hemorrhage (SAH). Transl Stroke Res. 5:681–691. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Turan N, Heider RA, Zaharieva D, Ahmad FU, Barrow DL and Pradilla G: Sex differences in the formation of intracranial aneurysms and incidence and outcome of subarachnoid hemorrhage: Review of experimental and human studies. Transl Stroke Res. 7:12–19. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Cheng C, Jiang L, Yang Y, Wu H, Huang Z and Sun X: Effect of APOE gene polymorphism on early cerebral perfusion after aneurysmal subarachnoid hemorrhage. Transl Stroke Res. 6:446–450. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Linn FH, Rinkel GJ, Algra A and van Gijn J: Incidence of subarachnoid hemorrhage: Role of region, year, and rate of computed tomography: A meta-analysis. Stroke. 27:625–629. 1996. View Article : Google Scholar : PubMed/NCBI

9 

Etminan N: Aneurysmal subarachnoid hemorrhage-status quo and perspective. Transl Stroke Res. 6:167–170. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Donahue RP, Abbott RD, Reed DM and Yano K: Alcohol and hemorrhagic stroke. The honolulu heart program. JAMA. 255:2311–2314. 1986. View Article : Google Scholar : PubMed/NCBI

11 

Stampfer MJ, Colditz GA, Willett WC, Speizer FE and Hennekens CH: A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 319:267–273. 1988. View Article : Google Scholar : PubMed/NCBI

12 

Iso H, Kitamura A, Shimamoto T, Sankai T, Naito Y, Sato S, Kiyama M, Iida M and Komachi Y: Alcohol intake and the risk of cardiovascular disease in middle-aged Japanese men. Stroke. 26:767–773. 1995. View Article : Google Scholar : PubMed/NCBI

13 

Sankai T, Iso H, Shimamoto T, Kitamura A, Naito Y, Sato S, Okamura T, Imano H, Iida M and Komachi Y: Prospective study on alcohol intake and risk of subarachnoid hemorrhage among Japanese men and women. Alcohol Clin Exp Res. 24:386–389. 2000. View Article : Google Scholar : PubMed/NCBI

14 

Klatsky AL, Armstrong MA, Friedman GD and Sidney S: Alcohol drinking and risk of hemorrhagic stroke. Neuroepidemiology. 21:115–122. 2002. View Article : Google Scholar : PubMed/NCBI

15 

Yamada S, Koizumi A, Iso H, Wada Y, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, et al: Risk factors for fatal subarachnoid hemorrhage: The Japan collaborative cohort study. Stroke. 34:2781–2787. 2003. View Article : Google Scholar : PubMed/NCBI

16 

Iso H, Baba S, Mannami T, Sasaki S, Okada K, Konishi M and Tsugane S: JPHC Study Group: Alcohol consumption and risk of stroke among middle-aged men: The JPHC study cohort I. Stroke. 35:1124–1129. 2004. View Article : Google Scholar : PubMed/NCBI

17 

Ikehara S, Iso H, Yamagishi K, Kokubo Y, Saito I, Yatsuya H, Inoue M and Tsugane S: JPHC Study group: Alcohol consumption and risk of stroke and coronary heart disease among Japanese women: The Japan public health center-based prospective study. Prev Med. 57:505–510. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Korja M, Silventoinen K, Laatikainen T, Jousilahti P, Salomaa V, Hernesniemi J and Kaprio J: Risk factors and their combined effects on the incidence rate of subarachnoid hemorrhage-a population-based cohort study. PLoS One. 8:e737602013. View Article : Google Scholar : PubMed/NCBI

19 

Gill JS, Shipley MJ, Tsementzis SA, Hornby RS, Gill SK, Hitchcock ER and Beevers DG: Alcohol consumption-a risk factor for hemorrhagic and non-hemorrhagic stroke. Am J Med. 90:489–497. 1991. View Article : Google Scholar : PubMed/NCBI

20 

Longstreth WT Jr, Nelson LM, Koepsell TD and van Belle G: Cigarette smoking, alcohol use, and subarachnoid hemorrhage. Stroke. 23:1242–1249. 1992. View Article : Google Scholar : PubMed/NCBI

21 

Kubota M, Yamaura A and Ono J: Prevalence of risk factors for aneurysmal subarachnoid haemorrhage: Results of a Japanese multicentre case control study for stroke. Br J Neurosurg. 15:474–478. 2001. View Article : Google Scholar : PubMed/NCBI

22 

Qureshi AI, Suri MF, Yahia AM, Suarez JI, Guterman LR, Hopkins LN and Tamargo RJ: Risk factors for subarachnoid hemorrhage. Neurosurgery. 49:607–613. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Ohkuma H, Tabata H, Suzuki S and Islam MS: Risk factors for aneurysmal subarachnoid hemorrhage in Aomori, Japan. Stroke. 34:96–100. 2003. View Article : Google Scholar : PubMed/NCBI

24 

Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B and He J: Alcohol consumption and risk of stroke: A meta-analysis. JAMA. 289:579–588. 2003. View Article : Google Scholar : PubMed/NCBI

25 

Zhang C, Qin YY, Chen Q, Jiang H, Chen XZ, Xu CL, Mao PJ, He J and Zhou YH: Alcohol intake and risk of stroke: A dose-response meta-analysis of prospective studies. Int J Cardiol. 174:669–677. 2014. View Article : Google Scholar : PubMed/NCBI

26 

Broderick JP, Brott T, Tomsick T, Miller R and Huster G: Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg. 78:188–191. 1993. View Article : Google Scholar : PubMed/NCBI

27 

Teunissen LL, Rinkel GJ, Algra A and van Gijn J: Risk factors for subarachnoid hemorrhage: A systematic review. Stroke. 27:544–549. 1996. View Article : Google Scholar : PubMed/NCBI

28 

Feigin VL, Rinkel GJ, Lawes CM, Algra A, Bennett DA, van Gijn J and Anderson CS: Risk factors for subarachnoid hemorrhage: An updated systematic review of epidemiological studies. Stroke. 36:2773–2780. 2005. View Article : Google Scholar : PubMed/NCBI

29 

Moher D, Liberati A, Tetzlaff J and Altman DG: PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 6:e10000972009. View Article : Google Scholar : PubMed/NCBI

30 

Wells GA, Shea B, O'Connell D, Peterson J, Welch V and Tugwell P: The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Available online. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htmAccessed. February 25–2016.

31 

Greenland S: Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 9:1–30. 1987.PubMed/NCBI

32 

Higgins JP and Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med. 21:1539–1558. 2002. View Article : Google Scholar : PubMed/NCBI

33 

Higgins JP, Thompson SG, Deeks JJ and Altman DG: Measuring inconsistency in meta-analyses. BMJ. 327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI

34 

Ali-Hassan-Sayegh S, Mirhosseini SJ, Tahernejad M, Mahdavi P, Haddad F, Shahidzadeh A, Lotfaliani MR, Sedaghat-Hamedani F, Kayvanpour E, Weymann A, et al: Administration of erythropoietin in patients with myocardial infarction: Does it make sense? An updated and comprehensive meta-analysis and systematic review. Cardiovasc Revasc Med. 16:179–189. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Egger M, Smith G Davey, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI

36 

Begg CB and Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics. 50:1088–1101. 1994. View Article : Google Scholar : PubMed/NCBI

37 

Duval S and Tweedie R: Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 56:455–463. 2000. View Article : Google Scholar : PubMed/NCBI

38 

Galeone C, Malerba S, Rota M, Bagnardi V, Negri E, Scotti L, Bellocco R, Corrao G, Boffetta P, La Vecchia C and Pelucchi C: A meta-analysis of alcohol consumption and the risk of brain tumours. Ann Oncol. 24:514–523. 2013. View Article : Google Scholar : PubMed/NCBI

39 

Berlin JA, Longnecker MP and Greenland S: Meta-analysis of epidemiologic dose-response data. Epidemiology. 4:218–228. 1993. View Article : Google Scholar : PubMed/NCBI

40 

Greenland S and Longnecker MP: Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 135:1301–1309. 1992.PubMed/NCBI

41 

Ma Y, Zhang P, Wang F, Yang J, Liu Z and Qin H: Association between vitamin D and risk of colorectal cancer: A systematic review of prospective studies. J Clin Oncol. 29:3775–3782. 2011. View Article : Google Scholar : PubMed/NCBI

42 

Harrell FE Jr, Lee KL and Pollock BG: Regression models in clinical studies: Determining relationships between predictors and response. J Natl Cancer Inst. 80:1198–1202. 1988. View Article : Google Scholar : PubMed/NCBI

43 

Daniel S and Bereczki D: Alcohol as a risk factor for hemorrhagic stroke. Ideggyogy Sz. 57:247–256. 2004.PubMed/NCBI

44 

Hillbom M, Saloheimo P and Juvela S: Alcohol consumption, blood pressure, and the risk of stroke. Curr Hypertens Rep. 13:208–213. 2011. View Article : Google Scholar : PubMed/NCBI

45 

Andreasen TH, Bartek J Jr, Andresen M, Springborg JB and Romner B: Modifiable risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 44:3607–3612. 2013. View Article : Google Scholar : PubMed/NCBI

46 

Juvela S, Hillbom M, Numminen H and Koskinen P: Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 24:639–646. 1993. View Article : Google Scholar : PubMed/NCBI

47 

Anderson C, Ni Mhurchu C, Scott D, Bennett D, Jamrozik K and Hankey G: Australasian Cooperative Research on Subarachnoid Hemorrhage Study Group: Triggers of subarachnoid hemorrhage: Role of physical exertion, smoking, and alcohol in the Australasian cooperative research on subarachnoid hemorrhage study (ACROSS). Stroke. 34:1771–1776. 2003. View Article : Google Scholar : PubMed/NCBI

48 

Acuña MY and Cifuentes AL: Aneurismal subarachnoid hemorrhage in a Chilean population, with emphasis on risk factors. BMC Res Notes. 4:4642011. View Article : Google Scholar : PubMed/NCBI

49 

Broderick JP, Viscoli CM, Brott T, Kernan WN, Brass LM, Feldmann E, Morgenstern LB, Wilterdink JL and Horwitz RI: Hemorrhagic Stroke Project Investigators: Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke. 34:1375–1381. 2003. View Article : Google Scholar : PubMed/NCBI

50 

Jung SY, Bae HJ, Park BJ and Yoon BW: Acute Brain Bleeding Analysis Study Group: Parity and risk of hemorrhagic strokes. Neurology. 74:1424–1429. 2010. View Article : Google Scholar : PubMed/NCBI

51 

Bateman BT, Olbrecht VA, Berman MF, Minehart RD, Schwamm LH and Leffert LR: Peripartum subarachnoid hemorrhage: Nationwide data and institutional experience. Anesthesiology. 116:324–333. 2012. View Article : Google Scholar : PubMed/NCBI

52 

Juvela S: Prevalence of risk factors in spontaneous intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage. Arch Neurol. 53:734–740. 1996. View Article : Google Scholar : PubMed/NCBI

53 

Jiménez-Yepes CM and Londoño-Fernández JL: Risk of aneurysmal subarachnoid hemorrhage: The role of confirmed hypertension. Stroke. 39:1344–1346. 2008. View Article : Google Scholar : PubMed/NCBI

54 

Hamdan A, Barnes J and Mitchell P: Subarachnoid hemorrhage and the female sex: Analysis of risk factors, aneurysm characteristics, and outcomes. J Neurosurg. 121:1367–1373. 2014. View Article : Google Scholar : PubMed/NCBI

55 

Ben-Shlomo Y, Markowe H, Shipley M and Marmot MG: Stroke risk from alcohol consumption using different control groups. Stroke. 23:1093–1098. 1992. View Article : Google Scholar : PubMed/NCBI

56 

Jee SH, Park JW, Lee SY, Nam BH, Ryu HG, Kim SY, Kim YN, Lee JK, Choi SM and Yun JE: Stroke risk prediction model: A risk profile from the Korean study. Atherosclerosis. 197:318–325. 2008. View Article : Google Scholar : PubMed/NCBI

57 

Singh JK, Ranjan P, Kumari A, Dahale AS, Jha R and Das R: Types, outcome and risk factors of stroke in Tribal Patients. Int J Stroke. 8:675–680. 2013. View Article : Google Scholar : PubMed/NCBI

58 

Zhang J, Liu G, Arima H, Li Y, Cheng G, Shiue I, Lv L, Wang H, Zhang C, Zhao J, et al: Incidence and risks of subarachnoid hemorrhage in China. Stroke. 44:2891–2893. 2013. View Article : Google Scholar : PubMed/NCBI

59 

Lindekleiv H, Sandvei MS, Romundstad PR, Wilsgaard T, Njølstad I, Ingebrigtsen T, Vik A and Mathiesen EB: Joint effect of modifiable risk factors on the risk of aneurysmal subarachnoid hemorrhage: A cohort study. Stroke. 43:1885–1889. 2012. View Article : Google Scholar : PubMed/NCBI

60 

Vlak MH, Rinkel GJ, Greebe P, Greving JP and Algra A: Lifetime risks for aneurysmal subarachnoid haemorrhage: Multivariable risk stratification. J Neurol Neurosurg Psychiatry. 84:619–623. 2013. View Article : Google Scholar : PubMed/NCBI

61 

Shiue I, Arima H, Hankey GJ and Anderson CS: ACROSS Group: Modifiable lifestyle behaviours account for most cases of subarachnoid haemorrhage: A population-based case-control study in Australasia. J Neurol Sci. 313:92–94. 2012. View Article : Google Scholar : PubMed/NCBI

62 

Koshy L, Easwer HV, Premkumar S, Alapatt JP, Pillai AM, Nair S, Bhattacharya RN and Banerjee M: Risk factors for aneurysmal subarachnoid hemorrhage in an Indian population. Cerebrovasc Dis. 29:268–274. 2010. View Article : Google Scholar : PubMed/NCBI

63 

Inagawa T: Risk factors for aneurysmal subarachnoid hemorrhage in patients in Izumo City, Japan. J Neurosurg. 102:60–67. 2005. View Article : Google Scholar : PubMed/NCBI

64 

Harmsen P, Rosengren A, Tsipogianni A and Wilhelmsen L: Risk factors for stroke in middle-aged men in Goteborg, Sweden. Stroke. 21:223–229. 1990. View Article : Google Scholar : PubMed/NCBI

65 

Inagawa T: Risk factors for the formation and rupture of intracranial saccular aneurysms in Shimane, Japan. World Neurosurg. 73:155–164, e23. 2010. View Article : Google Scholar : PubMed/NCBI

66 

Sandvei MS, Romundstad PR, Müller TB, Vatten L and Vik A: Risk factors for aneurysmal subarachnoid hemorrhage in a prospective population study: The HUNT study in Norway. Stroke. 40:1958–1962. 2009. View Article : Google Scholar : PubMed/NCBI

67 

Lindekleiv H, Sandvei MS, Njølstad I, Løchen ML, Romundstad PR, Vatten L, Ingebrigtsen T, Vik A and Mathiesen EB: Sex differences in risk factors for aneurysmal subarachnoid hemorrhage: A cohort study. Neurology. 76:637–643. 2011. View Article : Google Scholar : PubMed/NCBI

68 

Sankai T, Iso H, Shimamoto T, Kitamura A, Naito Y, Sato S, Okamura T, Imano H, Iida M and Komachi Y: Cohort study on risk factors for subarachnoid hemorrhage among Japanese men and women. Nihon Eiseigaku Zasshi. 53:587–595. 1999.(In Japanese). View Article : Google Scholar : PubMed/NCBI

69 

Leppälä JM, Paunio M, Virtamo J, Fogelholm R, Albanes D, Taylor PR and Heinonen OP: Alcohol consumption and stroke incidence in male smokers. Circulation. 100:1209–1214. 1999. View Article : Google Scholar : PubMed/NCBI

70 

Thompson SG: Why sources of heterogeneity in meta-analysis should be investigated. BMJ. 309:1351–1355. 1994. View Article : Google Scholar : PubMed/NCBI

71 

Feigin V, Parag V, Lawes CM, Rodgers A, Suh I, Woodward M, Jamrozik K and Ueshima H: Asia Pacific Cohort Studies Collaboration: Smoking and elevated blood pressure are the most important risk factors for subarachnoid hemorrhage in the Asia-Pacific region: An overview of 26 cohorts involving 306,620 participants. Stroke. 36:1360–1365. 2005. View Article : Google Scholar : PubMed/NCBI

72 

Canhão P, Pinto AN, Ferro H and Ferro JM: Smoking and aneurysmal subarachnoid haemorrhage: A case-control study. J Cardiovasc Risk. 1:155–158. 1994. View Article : Google Scholar : PubMed/NCBI

73 

Stokes GS: Hypertension and alcohol: Is ther a link? J Chronic Dis. 35:759–762. 1982. View Article : Google Scholar : PubMed/NCBI

74 

Moncada S and Radomski MW: The problems and the promise of prostaglandin influences in atherogenesis. Ann N Y Acad Sci. 454:121–130. 1985. View Article : Google Scholar : PubMed/NCBI

75 

Laug WE: Ethyl alcohol enhances plasminogen activator secretion by endothelial cells. JAMA. 250:772–776. 1983. View Article : Google Scholar : PubMed/NCBI

76 

Knekt P, Reunanen A, Aho K, Heliövaara M, Rissanen A, Aromaa A and Impivaara O: Risk factors for subarachnoid hemorrhage in a longitudinal population study. J Clin Epidemiol. 44:933–939. 1991. View Article : Google Scholar : PubMed/NCBI

77 

Bonita R: Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: A population-based case-control study. Stroke. 17:831–835. 1986. View Article : Google Scholar : PubMed/NCBI

78 

Petitti DB and Wingerd J: Use of oral contraceptives, cigarette smoking, and risk of subarachnoid haemorrhage. Lancet. 2:234–235. 1978. View Article : Google Scholar : PubMed/NCBI

79 

Longstreth WT, Nelson LM, Koepsell TD and van Belle G: Subarachnoid hemorrhage and hormonal factors in women. A population-based case-control study. Ann Intern Med. 121:168–173. 1994. View Article : Google Scholar : PubMed/NCBI

80 

Inman WH: Oral contraceptives and fatal subarachnoid haemorrhage. Br Med J. 2:1468–1470. 1979. View Article : Google Scholar : PubMed/NCBI

81 

Fedirko V, Tramacere I, Bagnardi V, Rota M, Scotti L, Islami F, Negri E, Straif K, Romieu I, La Vecchia C, et al: Alcohol drinking and colorectal cancer risk: An overall and dose-response meta-analysis of published studies. Ann Oncol. 22:1958–1972. 2011. View Article : Google Scholar : PubMed/NCBI

82 

Tramacere I, Negri E, Pelucchi C, Bagnardi V, Rota M, Scotti L, Islami F, Corrao G, La Vecchia C and Boffetta P: A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol. 23:28–36. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October-2016
Volume 5 Issue 4

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yao X, Zhang K, Bian J and Chen G: Alcohol consumption and risk of subarachnoid hemorrhage: A meta-analysis of 14 observational studies. Biomed Rep 5: 428-436, 2016
APA
Yao, X., Zhang, K., Bian, J., & Chen, G. (2016). Alcohol consumption and risk of subarachnoid hemorrhage: A meta-analysis of 14 observational studies. Biomedical Reports, 5, 428-436. https://doi.org/10.3892/br.2016.743
MLA
Yao, X., Zhang, K., Bian, J., Chen, G."Alcohol consumption and risk of subarachnoid hemorrhage: A meta-analysis of 14 observational studies". Biomedical Reports 5.4 (2016): 428-436.
Chicago
Yao, X., Zhang, K., Bian, J., Chen, G."Alcohol consumption and risk of subarachnoid hemorrhage: A meta-analysis of 14 observational studies". Biomedical Reports 5, no. 4 (2016): 428-436. https://doi.org/10.3892/br.2016.743